CMHC Masterclass CME Information

ACTIVITY TITLE

CMHC Masterclass: Connecting the Dots in Cardiometabolic Medicine - Integrative Approaches to Improve Patient Care

ACTIVITY DATE

April 29-30, 2022 at the Diplomat Beach Resort in Hollywood, FL

EDUCATIONAL SUPPORT

This activity is supported in part by an educational grant from Lilly USA, LLC.

TARGET AUDIENCE

US-based healthcare professionals, including primary care clinicians (PCPs), cardiologists, integrative medicine clinicians, registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.

PROGRAM OVERVIEW

Utilizing thought-provoking and interactive discussions, multidisciplinary experts in this masterclass will cover advances in lifestyle, nutrition, genetics, and pharmacotherapy to prevent and address obesity, cardiovascular disease, hypertension, dyslipidemia, type 2 diabetes, kidney disease and more. Each section will include expert panel discussions, which will aim to provide practical approaches to patient management and interpret the latest advances to patient care.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
• Review the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
• Outline strategies aimed at timely screening and prevention of cardiometabolic disease.
• Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field.
• Select comprehensive treatment regimens for patients with cardiometabolic disease that utilize both lifestyle interventions and pharmacotherapy to improve outcomes.
• Recognize obesity as a disease and the importance of long-term weight loss as an important therapeutic target in patients with type 2 diabetes and obesity.
• Select antiglycemic therapies with a favorable profile on weight and weight management in patients with obesity and type 2 diabetes when appropriate.
• Review the efficacy and safety of current, new, and emerging therapies for long-term weight management in patients with type 2 diabetes and obesity.
• Select individualized treatment options that optimize glycemic and weight control in patients with obesity and type 2 diabetes based on available options, recommendations, and patient preferences.

FACULTY

Please click here to view all faculty listings.

PROGRAM AGENDA

Please click here to view the full agenda.

JOINT PROVIDERSHIP STATEMENT

This activity is jointly provided by Global Education Group and Cardiometabolic Health Congress.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Cardiometabolic Health Congress.  Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 14 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity

PHARMACIST ACCREDITATION STATEMENT

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 14 contact hour(s) (1.4 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Please refer to list below of Universal Activity Numbers.

DIETITIAN ACCREDITATION STATEMENT

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 14 Continuing Professional Education units (CPEUs) for completion of this activities / materials. CPE Provider #GE012

GLOBAL CONTACT INFORMATION
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].

HOW TO REQUEST CE CREDIT
Full information on how to claim CME credit will be available soon.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.

DISCLOSURES
Information on planner and faculty disclosure can be downloaded here

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Cardiometabolic Health Congress do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.